148 related articles for article (PubMed ID: 30718176)
1. Evaluation of bi-objective treatment planning for high-dose-rate prostate brachytherapy-A retrospective observer study.
Maree SC; Luong NH; Kooreman ES; van Wieringen N; Bel A; Hinnen KA; Westerveld H; Pieters BR; Bosman PAN; Alderliesten T
Brachytherapy; 2019; 18(3):396-403. PubMed ID: 30718176
[TBL] [Abstract][Full Text] [Related]
2. Automatic bi-objective parameter tuning for inverse planning of high-dose-rate prostate brachytherapy.
Maree SC; Bosman PAN; van Wieringen N; Niatsetski Y; Pieters BR; Bel A; Alderliesten T
Phys Med Biol; 2020 Apr; 65(7):075009. PubMed ID: 32028270
[TBL] [Abstract][Full Text] [Related]
3. Towards artificial intelligence-based automated treatment planning in clinical practice: A prospective study of the first clinical experiences in high-dose-rate prostate brachytherapy.
Barten DLJ; Pieters BR; Bouter A; van der Meer MC; Maree SC; Hinnen KA; Westerveld H; Bosman PAN; Alderliesten T; van Wieringen N; Bel A
Brachytherapy; 2023; 22(2):279-289. PubMed ID: 36635201
[TBL] [Abstract][Full Text] [Related]
4. GPU-accelerated bi-objective treatment planning for prostate high-dose-rate brachytherapy.
Bouter A; Alderliesten T; Pieters BR; Bel A; Niatsetski Y; Bosman PAN
Med Phys; 2019 Sep; 46(9):3776-3787. PubMed ID: 31236948
[TBL] [Abstract][Full Text] [Related]
5. Bi-objective optimization of catheter positions for high-dose-rate prostate brachytherapy.
van der Meer MC; Bosman PAN; Niatsetski Y; Alderliesten T; van Wieringen N; Pieters BR; Bel A
Med Phys; 2020 Dec; 47(12):6077-6086. PubMed ID: 33000874
[TBL] [Abstract][Full Text] [Related]
6. A GPU-based multi-criteria optimization algorithm for HDR brachytherapy.
Bélanger C; Cui S; Ma Y; Després P; Adam M Cunha J; Beaulieu L
Phys Med Biol; 2019 May; 64(10):105005. PubMed ID: 30970341
[TBL] [Abstract][Full Text] [Related]
7. Inter-observer evaluation of a GPU-based multicriteria optimization algorithm combined with plan navigation tools for HDR brachytherapy.
Bélanger C; Poulin É; Aubin S; Vigneault É; Martin AG; Foster W; Beaulieu L
Brachytherapy; 2022; 21(4):551-560. PubMed ID: 35585019
[TBL] [Abstract][Full Text] [Related]
8. Keeping your best options open with AI-based treatment planning in prostate and cervix brachytherapy.
Dickhoff LRM; Scholman RJ; Barten DLJ; Kerkhof EM; Roorda JJ; Velema LA; Stalpers LJA; Pieters BR; Bosman PAN; Alderliesten T
Brachytherapy; 2024; 23(2):188-198. PubMed ID: 38296658
[TBL] [Abstract][Full Text] [Related]
9. A gEUD-based inverse planning technique for HDR prostate brachytherapy: feasibility study.
Giantsoudi D; Baltas D; Karabis A; Mavroidis P; Zamboglou N; Tselis N; Shi C; Papanikolaou N
Med Phys; 2013 Apr; 40(4):041704. PubMed ID: 23556874
[TBL] [Abstract][Full Text] [Related]
10. Adaptation of the CVT algorithm for catheter optimization in high dose rate brachytherapy.
Poulin E; Fekete CA; Létourneau M; Fenster A; Pouliot J; Beaulieu L
Med Phys; 2013 Nov; 40(11):111724. PubMed ID: 24320432
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a Machine-Learning Algorithm for Treatment Planning in Prostate Low-Dose-Rate Brachytherapy.
Nicolae A; Morton G; Chung H; Loblaw A; Jain S; Mitchell D; Lu L; Helou J; Al-Hanaqta M; Heath E; Ravi A
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(4):822-829. PubMed ID: 28244419
[TBL] [Abstract][Full Text] [Related]
12. Urethra low-dose tunnels: validation of and class solution for generating urethra-sparing dose plans using inverse planning simulated annealing for prostate high-dose-rate brachytherapy.
Cunha JA; Pouliot J; Weinberg V; Wang-Chesebro A; Roach M; Hsu IC
Brachytherapy; 2012; 11(5):348-53. PubMed ID: 21937284
[TBL] [Abstract][Full Text] [Related]
13. A novel urethral sparing technique for high-dose-rate prostate brachytherapy after transurethral resection of the prostate.
Kunogi H; Cunha JAM; Chang AJ; Gadzinski AJ; Shinohara K; Hsu IC
Brachytherapy; 2017; 16(6):1113-1118. PubMed ID: 28869143
[TBL] [Abstract][Full Text] [Related]
14. Validation of automated post-adjustments of HDR prostate brachytherapy treatment plans by quantitative measures and oncologist observer study.
Dohlmar F; Morén B; Sandborg M; Smedby Ö; Valdman A; Larsson T; Carlsson Tedgren Å
Brachytherapy; 2023; 22(3):407-415. PubMed ID: 36739222
[TBL] [Abstract][Full Text] [Related]
15. Investigating the role of constrained CVT and CVT in HIPO inverse planning for HDR brachytherapy of prostate cancer.
Sachpazidis I; Hense J; Mavroidis P; Gainey M; Baltas D
Med Phys; 2019 Jul; 46(7):2955-2968. PubMed ID: 31055834
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the impact of real-time multicriteria optimizers integrated with interactive plan navigation tools for HDR brachytherapy.
Bélanger C; Poulin É; Cui S; Vigneault É; Martin AG; Foster W; Després P; Cunha JAM; Beaulieu L
Brachytherapy; 2020; 19(5):607-617. PubMed ID: 32713779
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of anatomy-based dwell position and inverse optimization in high-dose-rate brachytherapy of prostate cancer: a dosimetric comparison to a conventional cylindrical dwell position, geometric optimization, and dose-point optimization.
Yoshioka Y; Nishimura T; Kamata M; Harada H; Kanazawa K; Fuji H; Murayama S
Radiother Oncol; 2005 Jun; 75(3):311-7. PubMed ID: 15890425
[TBL] [Abstract][Full Text] [Related]
18. Knowledge-based inverse treatment planning for low-dose-rate prostate brachytherapy.
Guthier CV; Orio PF; Buzurovic I; Cormack RA
Med Phys; 2021 May; 48(5):2108-2117. PubMed ID: 33586191
[TBL] [Abstract][Full Text] [Related]
19. Early clinical experience with anatomy-based inverse planning dose optimization for high-dose-rate boost of the prostate.
Lachance B; Béliveau-Nadeau D; Lessard E; Chrétien M; Hsu IC; Pouliot J; Beaulieu L; Vigneault E
Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):86-100. PubMed ID: 12182978
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric impact of inter-observer catheter reconstruction variability in ultrasound-based high-dose-rate prostate brachytherapy.
Nicolae A; Murgic J; Kruljac I; Dubnitzky L; D'Alimonte L; Lu L; Cumal A; Law N; Morton G; Loblaw A; Chung HT; Ravi A
Brachytherapy; 2018; 17(2):306-312. PubMed ID: 29239812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
